Defence's Broad and Versatile Accum(R) Technology Platform Focus on Cancer Therapeutics #Biotechnology #CSEStocks #Chemicals #DTC.C #DTC.CA #DTCFF #Investing #Medical #OTC #OTCMarkets #OTCStocks #Pharmaceutical #Pharmaceuticals #SmallCaps
Vancouver, British Columbia--(Newsfile Corp. - September 12, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), one of the leading Canadian biotechnology companies, is pleased to announce its continuation to bringing innovative strategies aimed at targeting various indications related to immune-oncology.Whether using an antibody, cell-based vaccine or small molecule therapeutics, the common denominator in all of Defence's development products...
http://dlvr.it/Svz4vx
http://dlvr.it/Svz4vx
Comments
Post a Comment